|
May 1994
(pdf format)
May 1994
(pdf format)
May 1994
(pdf format)
May 1994
(pdf format)
|
Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery AATOD Lane Holden Award May 1, 2022 | 0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…
FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…
Resources Equal Parity On March 23, 2010, President Obama signed the Affordable Care Act (ACA) into law. This puts in place comprehensive health insurance reforms that will roll out over four years and beyond. Health reform includes several key steps in the next 4 years. Medicaid will be expanded to allow more people at the lowest…
to your representative in Congress Upcoming EventsThe next few years will be important and exciting for methadone maintenance treatment. The FDA will be handing over their authority to the Center for Substance Abuse Treatment and there will be changes in the methadone regulations to allow for physicians prescribing methadone. The DEA will remain involved in…
American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Pre Conference Session 8:30 AM – 5:45 PM April 12, 2003 Sharon Dow, MS Joint Commission Washington, DC Joanne Page, MSW Council On Accreditation New York, NY Walter Ginter NAMA Westport, CT J. Thomas Payte, MD Drug Dependence Associates San Antonio,…
Center for Substance Abuse Treatment December 4, 2001 Dear Opioid Treatment Program Sponsor: This letter is to apprize you of significant developments affecting opioid treatment programs. On November 30, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the approval of four accreditation bodies (enclosed) under the new opioid treatment program regulations (42 CFR…